Evidence map›Paper›PMID 36265885›Full record

ReviewJournal of breast cancer2022

Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer: An Updated Review.

Jee Suk Chang, Ji Hyun Chang, Nalee Kim, Yong Bae Kim, Kyung Hwan Shin, Kyubo Kim

Open access · goldAbstract readReview
In one paragraph

Review in Journal of breast cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jee Suk ChangDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7685-3382
Ji Hyun ChangDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5921-5522
Nalee KimDepartment of Radiation Oncology, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4742-2772
Yong Bae KimDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7573-6862
Kyung Hwan ShinDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5852-7644
Kyubo KimDepartment of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea. kyubokim.ro@gmail.com.ORCID https://orcid.org/0000-0001-6093-1294
Seoul National University · KREwha Womans University · KRSungkyunkwan University · KRYonsei University · KR

Funding

National Research Foundation of Korea 2019R1C1C1009359Yonsei University College of Medicine 6-2021-0233
6 · The paper itself

Abstract

Radiation therapy (RT) plays a critical role in breast cancer treatment. In the modern technological era, innovations and progress in breast RT and delivery techniques have greatly improved the clinical outcomes. Intensity-modulated RT (IMRT) is a modern RT technology that permits the modulation of RT beams, ensuring a more uniform dose distribution through the target tissue and better avoidance of underlying critical structures. Recently, several studies have been published on breast IMRT. However, the interpretation of these results can be challenging because of the wide diversity of patients and treatment. The purpose of this study was to review these studies, focusing on the impact of IMRT on reducing toxicity and increasing convenience, as well as addressing concerns regarding breast IMRT.

Indexed as

Breast NeoplasmsRadiotherapyRadiotherapy, Intensity-Modulated

Identifiers

PMID36265885
PMCPMC9629965
OpenAlexW4295856932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.